Skip to main content
. 2022 Mar 3;16(2):128–145. doi: 10.1007/s13206-022-00052-5

Fig. 4.

Fig. 4

Synthetic-polymer-based nanoparticles for cancer therapy and vaccination. a Mice harboring two CT26 colon carcinoma tumors were treated intratumorally in one of the tumors with either Ox40l + Cd80/86 mRNA-CARTs or control mRNA-CARTs (Reproduced with permission from [52]

Copyright 2019, Cancer Research). b Design of macrophage-targeted polymeric NPs based on poly(beta-amino ester) formulated with mRNAs encoding key regulators of macrophage polarization (Reproduced with permission from [53] Copyright 2019, Nature Communication). c Graphical abstract of polyglucin:spermidine conjugate as a carrier of an mRNA-RBD vaccine encoding the receptor-binding domain (RBD) of the SARS-CoV-2 spike protein (reproduced with permission from [59] Copyright 2021, Vaccines). d Responsivity of PMs (PEG-PAsp(DET/GlcAm) to ATP. Gel electrophoresis was performed after incubation of PMs with several concentrations of ATP (reproduced with permission from [61] Copyright 2021, Journal of Controlled Release)